北京人福军威医药技术开发有限公司

Beijing Renfu Junwei Pharmaceutical Technology Development is a specialized research and development subsidiary of Humanwell Healthcare Group, primarily focused on the central nervous system (CNS) therapeutic area. The company excels in the development of innovative and high-end generic drugs for anesthesia, analgesia, and emergency medicine. It is well-known for its collaborative efforts with military medical institutions, facilitating the translation of military medical research into commercial healthcare solutions. Renfu Junwei's portfolio includes key products such as nalbuphine hydrochloride and etomidate, which are widely used in clinical settings across China. The company continues to advance its pipeline in pain management and sedative therapeutics to support its parent company's market leadership.